| Literature DB >> 21625504 |
Xiaoli Xue1, Helena Sztajer, Nora Buddruhs, Jörn Petersen, Manfred Rohde, Susanne R Talay, Irene Wagner-Döbler.
Abstract
The delta subunit of the RNA polymerase, RpoE, maintains the transcriptional specificity in gram-positive bacteria. Lack of RpoE results in massive changes in the transcriptome of the human dental caries pathogen Streptococcus mutans. In this study, we analyzed traits of the ΔrpoE mutant which are important for biofilm formation and interaction with oral microorganisms and human cells and performed a global phenotypic analysis of its physiological functions. The ΔrpoE mutant showed higher self-aggregation compared to the wild type and coaggregated with other oral bacteria and Candida albicans. It formed a biofilm with a different matrix structure and an altered surface attachment. The amount of the cell surface antigens I/II SpaP and the glucosyltransferase GtfB was reduced. The ΔrpoE mutant displayed significantly stronger adhesion to human extracellular matrix components, especially to fibronectin, than the wild type. Its adhesion to human epithelial cells HEp-2 was reduced, probably due to the highly aggregated cell mass. The analysis of 1248 physiological traits using phenotype microarrays showed that the ΔrpoE mutant metabolized a wider spectrum of carbon sources than the wild type and had acquired resistance to antibiotics and inhibitory compounds with various modes of action. The reduced antigenicity, increased aggregation, adherence to fibronection, broader substrate spectrum and increased resistance to antibiotics of the ΔrpoE mutant reveal the physiological potential of S. mutans and show that some of its virulence related traits are increased.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21625504 PMCID: PMC3098267 DOI: 10.1371/journal.pone.0020075
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Self-aggregation of S. mutans wild type (▪) and the ΔrpoE mutant (□).
Bacterial cells were in PBS buffer without (solid lines) and with Proteinase K treatment (dashed lines). Percent of aggregation was calculated as (OD600 at time zero−OD600 at time×min)/(OD600 at time zero)×100%. The representative results from three independent experiments are shown. The ΔrpoE mutant showed higher self-aggregation compared to the wild type. Pre-treatment with Proteinase K diminished the self-aggregation of the ΔrpoE mutant.
Coaggregation of S. mutans wild type (WT) and ΔrpoE mutant with oral microorganisms without (A)/with (B) Proteinase K treatment.
| A | ||||||||||||
|
|
|
|
|
|
| |||||||
|
| − | 0.23 | + | 0.14 | − | 0.10 | − | 0.24 | − | 0.24 | − | 0.23 |
|
| ++ | 0.08 | + | 0.07 | + | 0.17 | nd | nd | + | 0.12 | ||
|
| − | 0.08 | − | 0.20 | − | 0.24 | − | 0.14 | ||||
|
| − | 0.29 | − | 0.30 | − | 0.22 | ||||||
|
| − | 0.30 | − | 0.22 | ||||||||
|
| − | 0.20 | ||||||||||
The settlement of flocs is record after 90 minutes as shown in the first column, the number of ‘+’ indicates the strength of floc settlement, while ‘−’ indicates no visible coaggregation flocs, and ‘nd’ means not determined. The optical density (OD600) of the supernatant is also recorded as shown in the second column. Since each strain had a similar optical density before mixing, the turbidity changes helped to judge coaggregation strength.
Coaggregation of sucrose grown S. mutans wild type (WT) and ΔrpoE mutant with oral microorganisms without (A)/with (B) Proteinase K treatment.
| A | ||||||||||||
|
|
|
|
|
|
| |||||||
|
| ++++ | 0.01 | ++++ | 0.01 | +++ | 0.05 | ++ | 0.13 | +++ | 0.09 | ++ | 0.15 |
|
| ++++ | 0.01 | +++ | 0.08 | ++ | 0.13 | +++ | 0.11 | + | 0.19 | ||
|
| − | 0.23 | + | 0.19 | + | 0.15 | − | 0.15 | ||||
|
| − | 0.32 | + | 0.20 | +/− | 0.27 | ||||||
|
| + | 0.18 | + | 0.24 | ||||||||
|
| +/− | 0.28 | ||||||||||
Same as in table 1.
Figure 2Scanning electron microscopy of 16 h old biofilms of S. mutans strains.
Wild type (A, C); ΔrpoE mutant (B, D). The ΔrpoE mutant had a different structure of the biofilm matrix compared to the wild type. The red arrow shows the dendrite-like structure of the ΔrpoE mutant biofilm that attached to the polystyrene surface. The bars in image A, B indicate 5 µm, while in image C, D they indicate 2 µm.
Figure 3Quantification of extracellular polysaccharides (A), proteins (B), and DNA (C) in S. mutans biofilms.
Blue columns: wild type; red columns: ΔrpoE mutant. Two different methods were used for the extraction of proteins, including EDTA/NaOH and triton extraction. Mean value and standard deviation were calculated from three biological replicates.
Figure 4Extracellular matrix proteins of S. mutans biofilms.
Similar protein amounts extracted from 16 h old biofilms of the wild type (WT) and the ΔrpoE mutant were subjected to the 7.5% SDS-PAGE gel electrophoresis and stained by Coomassie blue. Prestained protein marker (M) was used, with the first three reference bands having a molecular weight of 250, 150, and 100 kD, respectively. Proteins were excised and identified by MALDI-TOF (see Table S1). The ΔrpoE mutant had a reduced expression of the surface antigen I/II SpaP and glucosyltransferase GtfB, while an increased expression of fructan hydrolase FruA can be seen. The lower band was probably truncated glucosyltransferase GtfD, thus marked as GtfD'.
Figure 5Adherence of S. mutans strains to human extracellular matrix (ECM) components.
Blue columns: wild type; red columns: ΔrpoE mutant. The mean value and standard deviation were calculated from five biological replicates. The ΔrpoE mutant adhered more strongly to all tested ECM compounds than the wild type. Binding was especially pronounced for fibronectin.
Figure 6Adherence of S. mutans wild type and the ΔrpoE mutant to human epithelial cells HEp-2.
(A) Quantification of adherent bacteria on HEp-2 cells. The mean value and standard deviation of the ratio of bacteria/HEp-2 cells was calculated from six biological replicates obtained from three independent experiments. More wild type cells adhered to HEp-2 cells. The scanning electron microscope images show the attachment of wild type (B) and the ΔrpoE mutant (C) to the surface of human epithelial cells HEp-2. The ΔrpoE mutant cells were clumping together. The bars indicate 2 µm.
Figure 7Invasion of human epithelial HEp-2 cells by S. mutans wild type cells.
The scanning electron microscope image was recorded after 4 hours of incubation of the bacterial culture with HEp-2 cells. The bar indicates 2 µm.
Figure 8Phenotype Microarray comparison of carbon source utilization by the ΔrpoE mutant compared to the wild type.
190 different substrates were tested in the plates PM 1 and PM 2 plates. The metabolic responses of the mutant and the wild type are presented in green and red, respectively, and shared signals are shown in yellow. Black boxes indicate the 20 carbon sources that are exclusively utilized by the mutant, which are reproducible in both experiments. The arrows represent different sugar types that can be metabolized by the ΔrpoE mutant, e.g. D-galactose (monosaccharide), sucrose (disaccharide), raffinose (trisaccharide), stachyose (tetrasaccharide), and D-mannitol (sugar alcohol).
Gained and lost metabolic activity in carbon sources utilization in the S. mutans ΔrpoE mutant compared to the wild type.
| Phenotypes Gained - better metabolic activity | ||||
| Plate | Wells | Test | Type of sugar | Pathway involved |
| PM01 | A03 | N-Acetyl-D-Glucosamine | Monosaccharide derivative of glucose | Amino sugar and nucleotide sugar metabolism |
| PM01 | A06 | D-Galactose | Monosaccharide | Galactose metabolism |
| PM01 | A10 | D-Trehalose | Disaccharide | Starch and sucrose metabolism |
| PM01 | B11 | D-Mannitol | Sugar alcohol | Fructose and mannose metabolism |
| PM01 | C07 | D-Fructose | Monosaccharide | Fructose and mannose metabolism |
| PM01 | C09 | α-D-Glucose | Monosaccharide | Glycolysis/Gluconeogenesis |
| PM01 | C10 | Maltose | Disaccharide | Starch and sucrose metabolism |
| PM01 | C11 | D-Melibiose | Disaccharide | Galactose metabolism |
| PM01 | D09 | α-D-Lactose | Disaccharide | Galactose metabolism |
| PM01 | D10 | Lactulose | Disaccharide | - |
| PM01 | D11 | Sucrose | Disaccharide | Galactose metabolism;Starch and sucrose metabolism |
| PM01 | E08 | β-Methyl-D-Glucoside | Monosaccharide derivative of glucose | - |
| PM01 | E10 | Maltotriose | Trisaccharide | Starch and sucrose metabolism |
| PM01 | F11 | D-Cellobiose | Disaccharide | Starch and sucrose metabolism |
| PM02 | A06 | Dextrin | Mixtures of polymers of D-glucose units | Starch and sucrose metabolism |
| PM02 | B08 | Arbutin | Glycosylated hydroquinone | Glycolysis/Gluconeogenesis |
| PM02 | C01 | Gentiobiose | Disaccharide | - |
| PM02 | D01 | D-Raffinose | Trisaccharide | Galactose metabolism |
| PM02 | D02 | Salicin | Alcoholic β-glycoside that contains D-glucose | Glycolysis/Gluconeogenesis |
| PM02 | D05 | Stachyose | Tetrasaccharide | Galactose metabolism |
Wells were scored positive if the difference in the height of the metabolic curve was above the threshold value in one experiment and a similar result occurred in the second experiment, albeit sometimes below the threshold value.
Acquired resistance to antibiotics and toxic compounds in the S. mutans ΔrpoE mutant compared to the wild type.
| Mode of Action | Compounds |
| DNA synthesis | Hexaminecobalt (III) Chloride, Nitrofurantoin, Bleomycin, Trifluoperazine, Myricetin, 5-Fluoro-5′-deoxyuridine, Semicarbazide hydrochloride, Trifluoperazine |
| DNA intercalator | 9-Aminoacridine, 2- Phenylphenol, Coumarin, Umbelliferone |
| DNA methyltransferase | 5-Azacytidine |
| DNA topoisomerase | Norfloxacin, Ciprofloxacin |
| DNA unwinding | Oxolinic acid, Pipemidic Acid, Lomefloxacin, Enoxacin, Ofloxacin, Nalidixic acid |
| folate antagonist | Sulfadiazine, Sulfamethazine, Sulfamethoxazole, Sulfathiazole, Sulfanilamide, Sulfachloropyridazine, Sulfamonomethoxine, Trimethoprim, Sulfisoxazole |
| Nucleic acid analogs | Azathioprine, 5-Fluorouracil, Cytosine arabinoside |
| thymidylate synthetase | Trifluorothymidine |
| ribonucleotide DP reductase | 3,5- Diamino-1,2,4-triazole (Guanazole) |
| protein synthesis | Phenyl-Methyl-Sulfonyl-Fluoride (PMSF), Capreomycin, Spectinomycin, Chloramphenicol, Cinoxacin, Blasticidin S, Rolitetracycline, Tylosin, Oleandomycin, Paromomycin, Tobramycin, Geneticin (G418), Streptomycin, Hygromycin B, Spiramycin, Josamycin, Tetracycline, Amikacin, Gentamicin, Kanamycin, Neomycin, Erythromycin |
| tRNA synthetase | D,L-Serine Hydroxamate, L-Aspartic-b-Hydroxamate, L-Glutamic-g-Hydroxamate |
| Cell wall synthesis | Glycine, Phosphomycin, Cefoxitin, Cetoperazone, Ampicillin, Moxalactam, Piperacillin, Aztreonam, D-Cycloserine, Cefazolin, Ceftriaxone |
| toxic anions | Sodium bromated, Sodium periodate, Potassium chromate, Sodium Cyanate, Sodium Arsenate, Sodium Dichromate, Sodium metasilicate, Cobalt chloride, Zinc chloride, Chromium Chloride |
| toxic cations | Cesium chloride, Nickel chloride, Thallium (I) acetate, Aluminum Sulfate |
| Toxicity | 5-Fluoroorotic Acid, Sodium Nitrate, Sodium Phosphate |
| membrane | Cetylpyridinium Chloride, Polymyxin B, Colistin |
| Chelating agents | Sodium pyrophosphate decahydrate, 2,2′-Dipyridyl, 1-Hydroxy-Pyridine-2-thione, Fusaric Acid, 1,10-Phenanthroline |
| fungicide | Chloroxylenol, Dodine, Nordihydroguaiaretic acid |
| oxidation | 1-Chloro-2,4-Dinitrobenzene, Diamide, Methyl viologen, 3, 4-Dimethoxybenzyl alcohol, Phleomycin |
| respiration | 18-Crown-6-Ether, Sorbic Acid, Pentachlorophenol (PCP), Menadione, Sodium azide, Ruthenium red |
| Others | X-α-D-Galactoside, X-β-D-Glucoside, X-β-D-Glucuronide, Atropine, Thiosalicylate, Apramycin, Ethionamide, X-PO4, X-SO4, Triclosan, D,L-Propranolol, Caffeine, Aminotriazole, Harmane, D-Serine, Dequalinium, Lidocaine, Tinidazole, 20% Ethylene Glycol, pH 8, Phenylarsine Oxide, b-Chloro-L-Alanine, Trifluoperazine |
S. mutans ΔrpoE mutant contains an erythromycin resistance gene.
mode of action includes: α-D-galactosidase, β-D-glucosidase, β-D-glucuronidase, acetylcholine receptor, anti-capsule, antimicrobial, anti-tuberculosic, aryl phosphatase, aryl sulfatase, bacterial fatty acid synthesis, beta-adrenergic blocker, cyclic AMP phosphodiesterase, histidine biosynthesis, imidazoline binding sites, 3PGA dehydrogenase inhibitor, ion channel inhibitor, mutagen, osmotic sensitivity, pH sensitivity, tyrosine phosphatase, aminotransferase inhibitor.